Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 1, 2012, Pages

  Nelsen, Linda M ^a   Shields, Kristine E ^a   Cunningham, Michael L ^b   Stoler, Joan M ^d   Bamshad, Michael J ^c   Eng, P Mona ^e   Smugar, Steven S ^a   Gould, A Lawrence ^a   Philip, George ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e I3 Drug Safety   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MONTELUKAST; SHORT ACTING DRUG;

ASTHMA; BIRTH DEFECT; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; HUMAN; LETTER; LIMB MALFORMATION; LIMB REDUCTION DEFECT; NONHUMAN; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPINA BIFIDA; TERATOGENICITY;

EID: 84455205713     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.09.003     Document Type: Article

References (16)

1. NAEPP expert panel report Managing asthma during pregnancy: recommendations for pharmacologic treatment - 2004 update J Allergy Clin Immunol 115 2005 34 46
2. L. Blais, F.Z. Kettani, N. Elftouh, and A. Forget Effect of maternal asthma on the risk of specific congenital malformations: a population-based cohort study Birth Defects Res A Clin Mol Teratol 88 2010 216 222
3. M.P. Dombrowski, and M. Schatz ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy Obstet Gynecol 111 2008 457 464
4. M. Schatz, M.P. Dombrowski, R. Wise, V. Momirova, M. Landon, and W. Mabie The relationship of asthma medication use to perinatal outcomes J Allergy Clin Immunol 113 2004 1040 1045
5. L.N. Bakhireva, K.L. Jones, M. Schatz, H.S. Klonoff-Cohen, D. Johnson, and D.J. Slymen Safety of leukotriene receptor antagonists in pregnancy J Allergy Clin Immunol 119 2007 618 625
6. M. Sarkar, G. Koren, S. Kalra, A. Ying, C. Smorlesi, and M. De Santis Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes Eur J Clin Pharmacol 65 2009 1259 1264
7. Pregnancy registry for SINGULAIR(R): the 8th annual report - 2006 2007 Merck Research Laboratories West Point (PA)
8. Singulair (montelukast sodium) Prescribing Information 2010 Merck & Co, Inc Whitehouse Station (NJ)
9. L.B. Holmes Teratogen-induced limb defects Am J Med Genet 112 2002 297 303
10. A. Rosano, L.D. Botto, R.S. Olney, M.J. Khoury, A. Ritvanen, and J. Goukard Limb defects associated with major congenital anomalies: clinical and epidemiological study from the International Clearinghouse for Birth Defects Monitoring Systems Am J Med Genet 93 2000 110 116
11. J.A. Cole, J.G. Modell, B.R. Haight, I.S. Cosmatos, J.M. Stoler, and A.M. Walker Bupropion in pregnancy and the prevalence of congenital malformations Pharmacoepidemiol Drug Saf 16 2007 474 484
12. J.A. Cole, S.A. Ephross, I.S. Cosmatos, and A.M. Walker Paroxetine in the first trimester and the prevalence of congenital malformations Pharmacoepidemiol Drug Saf 16 2007 1075 1085
13. M.A. Raebel, J.L. Ellis, and S.E. Andrade Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data Pharmacoepidemiol Drug Saf 14 2005 829 836
14. A. Vilain, S. Otis, A. Forget, and L. Blais Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women Pharmacoepidemiol Drug Saf 17 2008 345 353
15. G.G. Briggs Drug effects on the fetus and breast-fed infant Clin Obstet Gynecol 45 2002 6 21
16. G. Koren, A. Pastuszak, and S. Ito Drugs in pregnancy N Engl J Med 338 1998 1128 1137